|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 28, 2017) - VANC Pharmaceuticals Inc. (TSX VENTURE:VANC)(OTCQB:NUVPF) ("VANC" or the "Company"), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets, provides a corporate update. |
